Delivery Order SPE2DB22D3102-SPE2DB26FK8TE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2ML) on September 10, 2025, with a ceiling value of $13,268.58. This firm fixed-price delivery order, which carries an ultimate completion date of September 11, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The contract was competitively awarded with no set-aside designation and will be performed at the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,647.66 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine in 2 milliliter units. This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award does not carry a set-aside designation, indicating it was competed among...
- The Defense Logistics Agency awarded a delivery order valued at $3,286.08 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine in 2ML units. The contract, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, operates under firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,671.82 to AmerisourceBergen Drug Corp for RotaTeq Vaccine 2ML on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of RotaTeq vaccine in 2 mL units, with a ceiling value of $1,370.61. This is a firm fixed-price delivery order with an ultimate completion date of October 31, 2025, and represents a child contract issued under AmerisourceBergen's larger pharmaceutical supply vehicle. The award involves no set-aside designation, indicating it was competitively awarded. The place of...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2ML) with a ceiling value of $1,614.81. This non-competitive, firm fixed-price delivery order was awarded on June 25, 2025, with completion scheduled for June 26, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, serving as the place of performance. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $3,126.67 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) on September 16, 2025, with completion targeted for September 17, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to the company's distribution facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,614.81 to AmerisourceBergen Drug Corp for RotaTeq vaccine (2ml) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,746.10 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2ML formulation) on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $4,150.39 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB26FK8TEDelivery Order
The Defense Logistics Agency awarded a $1,076.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2mL) on October 29, 2025, with an ultimate completion date of October 30, 2025. The contract is unclassified as a set-aside and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor through its comprehensive IDC vehicle with the Defense Logistics Agency. The underlying contract supports military healthcare programs worldwide by enabling the supply of a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications across multiple therapeutic domains. This specific delivery order for RotaTeq vaccine supports the federal government's medical supply needs and reflects the contractor's established capability to fulfill federal procurement requirements through competitive contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/29/25 |